Albuterol nebulizer dosing in infants
Pro Research Analysisby 
Searched over 200M research papers
Albuterol Nebulizer Dosing in Infants: Recommended Dose and Efficacy
Standard Albuterol Nebulizer Dose for Infants
Multiple studies consistently use a nebulized albuterol dose of 0.15 mg/kg per treatment for infants and young children, including those under 2 years of age and as young as 6 weeks old. This dose is typically administered in two treatments, spaced one hour apart, and has been shown to be both safe and effective for acute asthma and bronchiolitis in this age group Bentur1992Schuh1990Schweich1992.
Clinical Effectiveness and Safety in Infants
Research shows that nebulized albuterol at 0.15 mg/kg per dose leads to significant improvements in clinical symptoms such as respiratory rate, wheezing, use of accessory muscles, and oxygen saturation in infants with acute asthma or bronchiolitis Bentur1992Schuh1990Schweich1992. The response to therapy is similar in infants younger and older than 6 months, and no serious side effects have been reported, aside from a slight increase in heart rate in some cases Schuh1990Gadomski1994. Importantly, no significant changes in heart rate or respiratory rate were observed between albuterol and placebo groups in some studies, and no evidence of toxicity was detected Torres1997Schweich1992.
Comparison with Other Delivery Methods
Studies comparing nebulized albuterol to metered-dose inhaler (MDI) administration in intubated infants found both methods to be equally safe and effective, with no significant difference in improvement of lung function . However, the generalizability of these results may be limited by differences in drug delivery devices and techniques.
Continuous Nebulized Albuterol
Continuous nebulized albuterol therapy has also been studied in infants and children with bronchospasm. It appears to be safe, with no significant evidence of cardiotoxicity or arrhythmias, even when administered for at least 24 hours .
Special Considerations in Delivery Efficiency
Recent research highlights that the efficiency of albuterol delivery can be significantly improved by optimizing nebulizer placement and gas flow within the delivery circuit, especially in mechanically ventilated or critically ill infants . Standard clinical practices may be less efficient, and simple adjustments can markedly increase the amount of drug delivered to the patient .
Conclusion
The recommended nebulized albuterol dose for infants is 0.15 mg/kg per treatment, typically given every 20 minutes to one hour as needed for acute symptoms. This dosing regimen is supported by multiple studies as safe and effective for infants with wheezing, acute asthma, or bronchiolitis. Continuous nebulized albuterol is also considered safe for prolonged use in this population. Delivery efficiency can be improved with careful attention to nebulizer setup, but the standard dosing remains consistent across studies Bentur1992Schuh1990Schweich1992+2 MORE.
Sources and full results
Most relevant research papers on this topic